|本期目录/Table of Contents|

[1]赵夕琛,靳育静,孙晓薇,等.利拉鲁肽对人胰岛淀粉样多肽聚集性及胰岛细胞毒性的影响[J].天津医科大学学报,2021,27(06):608-613.
　ZHAO Xi-chen,JIN Yu-jing,SUN Xiao-wei,et al.Effect of liraglutide on the human islet amyloid polypeptide aggregation and cell toxicity[J].Journal of Tianjin Medical University,2021,27(06):608-613.
点击复制

利拉鲁肽对人胰岛淀粉样多肽聚集性及胰岛细胞毒性的影响(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年06期
页码:
608-613
栏目:
基础医学
出版日期:
2021-11-15

文章信息/Info

Title:
Effect of liraglutide on the human islet amyloid polypeptide aggregation and cell toxicity
文章编号:
1006-8147（2021）06-0608-06
作者:
赵夕琛1 ; 靳育静1; 孙晓薇1; 李代清2; 朱铁虹1
（1.天津医科大学总医院内分泌与代谢科,天津300052；2.天津医科大学朱宪彝纪念医院代谢病科,天津300134）
Author(s):
ZHAO Xi-chen1; JIN Yu-jing1; SUN Xiao-wei1; LI Dai-qing2; ZHU Tie-hong1
（1.Depatment of Endocrinology and Metabolism，General Hospital，Tianjin Medical University，Tianjin 300052，China; 2.Department of Metabolism，Chu Hisen-I Memorial Hospital，Tianjin Medical University，Tianjin 300134，China）
关键词:
利拉鲁肽; 人胰淀素; 聚集; 胰岛细胞
Keywords:
liraglutide;  human islet amyloid polypeptide; aggregation; islet cell
分类号:
R587.1
DOI:
-
文献标志码:
A
摘要:
目的：探讨利拉鲁肽对人胰岛淀粉样多肽聚集性及细胞毒性的影响。方法：采用硫磺素T荧光法检测淀粉样纤维聚集的动力学，采用透射电镜检测淀粉样纤维的形态。分离Wistar大鼠胰岛，采用简单随机化分组的方法将大鼠胰岛随机分配成空白对照组、人胰淀素组、人胰淀素+利拉鲁肽组。24 h后采用Annexin-V/PI荧光染色及逆转录聚合酶链反应检测细胞凋亡及炎性因子白细胞介素（IL）-1β、肿瘤坏死因子α（TNFα） 、单核细胞趋化蛋白-1（CCL-2） mRNA的表达。结果：人胰淀素单独孵育时，荧光于1.6 h左右开始上升，并随时间延长逐渐增加，3.4 h后平稳，动力学曲线呈S型曲线；人胰淀素与利拉鲁肽（500 nmol/L）以10∶1分子浓度共同孵育时，荧光信号上升延迟缓慢；以1∶1分子浓度共同孵育时，荧光信号未见明显增加，动力学曲线呈直线型。透射电镜结果显示，人胰淀素单独孵育可见大量长条状纤维聚集，人胰淀素与利拉鲁肽（2 μmol）以10∶1浓度共同孵育后纤维数量明显减少，且短小模糊；1:1（20 μmol利拉鲁肽）浓度共同孵育后，无法找到纤维结构。与空白对照组相比，人胰淀素组IL-1、TNFα、CCL-2基因的mRNA表达均增加，而人胰淀素+利拉鲁肽组表达均下降（F=429.68、48.79、153.39, 均 P＜0.05）。人胰淀素组细胞凋亡率与空白对照组相比明显升高；人胰淀素＋利拉鲁肽组凋亡率比人胰淀素组降低（F=514.34、16.14、18.47，均P＜0.05）。结论：利拉鲁肽抑制胰淀素聚集，减少胰岛细胞炎症及凋亡。
Abstract:
Objective： To explore the effect of liraglutide on human islet amyloid polypeptide（hIAPP）aggregation and cell toxicity. Methods： Thioflavin T（ThT） binding assays were used to test the real time characterization of hIAPP fibrils formation kinetics. The electron microscopy tests were used to test the morphology of hIAPP fibrils. Pancreatic islets were isolated from adult Wistar rats. The experiment groups included normal islets，hIAPP incubated islets，hIAPP and liraglutide co-incubated islets. The incubation time of three groups was 24 h. Annexin V/PI double-staining was used to detect islet cells apoptosis. The expression of inflammation-related and apoptosis-related genes was analyzed by reverse transcription-polymerase chain reaction. Results：ThT tests showed that 5 μmol/L hIAPP had undergone fibrillation after 1.6 h，reaching a maximum after 3.4 h，and the kinetic curve was S-shaped. When co-incubate with 500 nmol/L liraglutide (10:1)，hIAPP fibrillation delayed. When the molecular ratio reached 1∶1，the fluorescence signal did not increase significantly，and the kinetic curve was linear. Electron microscopy tests showed that 20 μmol hIAPP aggregates into the abundant fibrils，whereas in the presence of 2 μmol liraglutide（10∶1），the fibrils were much less and shorter. And when increasing the concentration of liraglutide（20 μmol，1∶1），there were no fibrils. Compared with the blank control group，the mRNA expression of IL-1，TNF and CCL-2 in amylin group was increased，while the expression in liraglutide intervention group was decreased with statistical significance（F=429.68，48.79，153.39，all P<0.05）. The annexin V/PI double-staining tests and RT-PCR showed that when treated with hIAPP，the apoptosis increased，which was decreased by liraglutide（F=514.34，16.14，18.47，all P＜0.05）. Conclusion：Liraglutide inhibits the aggregation of hIAPP and protects islets from inflammation and apoptosis.

参考文献/References:

[1] OPIE E L.On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes melutus[J]. J Exp Med，1901，5（4）：397
[2] CLARK A，WELLS C A，BULEY I D，et al. Islet amyloid，increased A-cells，reduced B-cells and exocrine fibrosis： quantitative changes in the pancreas in type 2 diabetes[J]. Diabetes Res，1988，9（4）：151
[3] EHSES J A，LACRAZ G，GIROIX M H，et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat[J]. Proc Natl Acad Sci U S A，2009，106（33）：13998
[4] GUARDADO-MENDOZA R，DAVALLI A M，CHAVEZ A O，et al.Pancreatic islet amyloidosis，beta-cell apoptosis，and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons[J]. Proc Natl Acad Sci U S A，2009，106（33）：13992
[5] EFTEKHARZADEH B，HYMAN B T，WEGMANN S. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases[J]. Mech Ageing Dev，2016，156：1
[6] CAILLON L，HOFFMANN A R，BOTZ A，et al. Molecular structure，membrane interactions，and toxicity of the islet amyloid polypeptide in type 2 diabetes mellitus[J]. J Diabetes Res，2016，2016：5639875
[7] AKTER R，CAO P，NOOR H，et al. Islet amyloid polypeptide： structure，function，and pathophysiology[J]. J Diabetes Res，2016，2016：2798269
[8] FEMMINELLA G D，FRANGOU E，LOVE S B，et al. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer′s disease： study protocol for a randomised controlled trial（ELAD study）[J]. Trials，2019，20（1）：191
[9] SALLES G N，CALI?譫 M L，H?魻LSCHER C，et al. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer′s disease[J]. Neuropharmacology，2020，162：107813
[10] LIVAK K J，SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2（-Delta Delta C（T）） Method[J]. Methods，2001，25（4）：402
[11] 靳育静，孙晓薇，李晓通，等. 白细胞介素1在介导人胰岛淀粉样多肽对胰岛细胞毒性中的作用及机制[J]. 中华糖尿病杂志，2017，9（3）：179
[12] MCCLEAN P L，H?魻LSCHER C. Liraglutide can reverse memory impairment，synaptic loss and reduce plaque load in aged APP/PS1 mice，a model of Alzheimer′s disease[J]. Neuropharmacology，2014，76（Pt A）：57
[13] PARK Y J ，ZHANG Y，WARNOCK G L，et al. Amyloid formation reduces protein kinase B phosphorylation in primary islet β-cells which is improved by blocking IL-1β signaling[J]. PLoS One，2018，13（2）：e0193184
[14] FORTIN J S，BENOIT-BIANCAMANO M O. Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs[J]. Can J Physiol Pharmacol，2016;94（1）：35
[15] WANG H，RIDGWAY Z，CAO P，et al. Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity[J]. Biochemistry，2015 ，54（44）：6704
[16] E l Bekay R，Coín-Aragüez L，Fernández-García D，et al. Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes[J]. Br J Pharmacol，2016，173（11）：1820
[17] FAN R，LI X，GU X，et al. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage： potential involvement of AKT and mitochondria biogenesis[J]. Diabetes Obes Metab，2010，12（9）：815
[18] ASTON-MOURNEY K，HULL R L，ZRAIKA S，et al. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets[J]. Diabetologia，2011，54（7）：1756
[19] HTIKE Z Z，ZACCARDI F，PAPAMARGARITIS D，et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes： a systematic review and mixed-treatment comparison analysis[J]. Diabetes Obes Metab，2017，19（4）：524
[20] DAI Y，DAI D，WANG X，et al. GLP-1 agonists inhibit ox-LDL uptake in macrophages by activating protein kinase A[J]. J Cardiovasc Pharmacol，2014，64（1）：47
[21] TOMITA T. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects[J]. Islets，2012，4（3）：223
[22] PARK Y J，WARNOCK G L，AO Z，et al. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity： implications for type 2 diabetes and islet transplantation[J]. Diabetes Obes Metab，2017，19（5）：682

相似文献/References:

备注/Memo

备注/Memo:
基金项目 国家自然科学基金项目（H0713：81241030）；天津市自然科学基金（M0102） 作者简介 赵夕琛（1993-），女，硕士在读，研究方向：内分泌与代谢病；通信作者：朱铁虹，E-mail：zhutiehong@163.com。
更新日期/Last Update: 2021-11-15